Reuters logo
BRIEF-Opiant Pharma appoints Phil Skolnick chief scientific officer
February 6, 2017 / 12:11 PM / in 8 months

BRIEF-Opiant Pharma appoints Phil Skolnick chief scientific officer

Feb 6 (Reuters) - Opiant Pharmaceuticals Inc

* Opiant pharmaceuticals, inc. Announces the appointment of dr. Phil skolnick as chief scientific officer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below